日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling study

将季节性疟疾化学预防与新型疟疾预防疗法相结合：一项数学建模研究

期刊:PLoS Computational Biology
影响因子:3.6
doi:10.1371/journal.pcbi.1014021
Braunack-Mayer, Lydia; Malinga, Josephine; Nekkab, Narimane; Kelly, Sherrie L; Möhrle, Jörg J; Penny, Melissa A
微生物学
疟疾
发表日期：2026
文献求助 收藏

Therapeutic development to accelerate malaria control through intentional intervention layering

通过有意识的干预分层来加速疟疾控制的治疗研发

期刊:Malaria Journal
影响因子:3
doi:10.1186/s12936-024-05222-4
Braunack-Mayer, Lydia; Nekkab, Narimane; Malinga, Josephine; Kelly, Sherrie L; Ansah, Evelyn; Moehrle, Joerg J; Penny, Melissa A
微生物学
疟疾
发表日期：2025
文献求助 收藏

Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden

针对儿童疟疾负担的改良型红细胞前疟疾疫苗的性能特征及其潜在的公共卫生影响

期刊:PLOS Global Public Health
影响因子:2.5
doi:10.1371/journal.pgph.0004549
Malinga, Josephine; Braunack-Mayer, Lydia; Masserey, Thiery; Cavelan, Aurélien; Chandramohan, Daniel; Dicko, Alassane; Ouédraogo, Jean-Bosco; Kelly, Sherrie L; Le Rutte, Epke A; Nekkab, Narimane; Penny, Melissa A
微生物学
细胞生物学
疟疾
红细胞
发表日期：2025
文献求助 收藏

Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study

为提高下一代季节性疟疾化学预防药物的公共卫生影响，设计和选择药物特性：一项建模研究

期刊:Lancet Global Health
影响因子:18
doi:10.1016/S2214-109X(23)00550-8
Braunack-Mayer, Lydia; Malinga, Josephine; Masserey, Thiery; Nekkab, Narimane; Sen, Swapnoleena; Schellenberg, David; Tchouatieu, André-Marie; Kelly, Sherrie L; Penny, Melissa A
微生物学
疟疾
发表日期：2024
文献求助 收藏

Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model

在巴西，使用G6PD筛查后服用他非诺喹与服用伯氨喹治疗间日疟的成本效益分析：基于传播模型的成本效益分析

期刊:PLoS Medicine
影响因子:9.9
doi:10.1371/journal.pmed.1004255
Price, David J; Nekkab, Narimane; Monteiro, Wuelton M; Villela, Daniel A M; Simpson, Julie A; Lacerda, Marcus V G; White, Michael T; Devine, Angela
G6PD
发表日期：2024
文献求助 收藏

Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil

利用新型血清学检测和治疗策略加速消除间日疟原虫：巴西的建模案例研究

期刊:Lancet Regional Health-Americas
影响因子:7.6
doi:10.1016/j.lana.2023.100511
Nekkab, Narimane; Obadia, Thomas; Monteiro, Wuelton M; Lacerda, Marcus V G; White, Michael; Mueller, Ivo
发表日期：2023
文献求助 收藏

Modelling to inform next-generation medical interventions for malaria prevention and treatment

建立模型以指导下一代疟疾预防和治疗医疗干预措施

期刊:
影响因子:
doi:10.1038/s43856-023-00274-0
Nekkab, Narimane; Malinga, Josephine; Braunack-Mayer, Lydia; Kelly, Sherrie L; Miller, R Scott; Penny, Melissa A
微生物学
疟疾
发表日期：2023
文献求助 收藏

Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi

间日疟原虫疟疾血清学暴露标志物：评估与诺氏疟原虫交叉反应的程度和影响

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2022.100662
Rhea J Longley, Matthew J Grigg, Kael Schoffer, Thomas Obadia, Stephanie Hyslop, Kim A Piera, Narimane Nekkab, Ramin Mazhari, Eizo Takashima, Takafumi Tsuboi, Matthias Harbers, Kevin Tetteh, Chris Drakeley, Chetan E Chitnis, Julie Healer, Wai-Hong Tham, Jetsumon Sattabongkot, Michael T White, Daniel
免疫
疟疾
Donkey
IgG Fc
发表日期：2022
文献求助 收藏

Accelerated development of malaria monoclonal antibodies

加速疟疾单克隆抗体的研发

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2022.100786
Nekkab, Narimane; Penny, Melissa A
单克隆抗体
疟疾
微生物学
发表日期：2022
文献求助 收藏

Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment

开发血清诊断检测方法以促进间日疟原虫血清学检测和治疗策略：构建公共卫生影响与过度治疗之间平衡的模型

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-022-02285-5
Obadia, Thomas; Nekkab, Narimane; Robinson, Leanne J; Drakeley, Chris; Mueller, Ivo; White, Michael T
发表日期：2022
文献求助 收藏